![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Efficacy of Sofosbuvir-Containing Regimens for Hepatitis C: Real-World Experience in a Diverse, Longitudinal Observational Cohort
|
|
|
Reported by Jules Levin
AASLD 2014 Nov 8-11 Boston
Jensen DM, O'Leary J, Pockros P, Sherman K, Kwo P, Mailliard M, Kowdley K, Muir A, Dickson R, Ramani A, Manns M, Lok A, Akushevich L, Nelson D and Fried M for the HCV-TARGET Study Group
![AASLD1.gif](../images/111014/111014-10/AASLD1.gif)
![AASLD2.gif](../images/111014/111014-10/AASLD2.gif)
![AASLD3.gif](../images/111014/111014-10/AASLD3.gif)
![AASLD4.gif](../images/111014/111014-10/AASLD4.gif)
![AASLD5.gif](../images/111014/111014-10/AASLD5.gif)
![AASLD6.gif](../images/111014/111014-10/AASLD6.gif)
![AASLD7.gif](../images/111014/111014-10/AASLD7.gif)
![AASLD8.gif](../images/111014/111014-10/AASLD8.gif)
![AASLD9.gif](../images/111014/111014-10/AASLD9.gif)
![AASLD10.gif](../images/111014/111014-10/AASLD10.gif)
![AASLD11.gif](../images/111014/111014-10/AASLD11.gif)
![AASLD12.gif](../images/111014/111014-10/AASLD12.gif)
![AASLD13.gif](../images/111014/111014-10/AASLD13.gif)
![AASLD14.gif](../images/111014/111014-10/AASLD14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|